转录组分类器不能可靠地预测淋巴结参与乳腺癌:来自三大队伍的见解
1Department of Histopathology, South Austin Hospital, Emeritus, Austin, TX, USA.
概括
在乳腺癌中,mRNA表达形状不能可靠地预测淋巴结状况. 目前的分子方法不能取代对淋巴结参与的外科评估.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 淋巴结 (LN) 状态是乳腺癌的关键预后指标.
- 对于LN参与的分子替代品可以改善风险分层和外科手术阶段.
- 这项研究探讨了mRNA表达特征作为LN状态的潜在预测因素.
研究的目的:
- 研究mRNA表达特征对淋巴结参与乳腺癌的预测能力.
- 为了比较机器学习模型的LN状态预测性能与组织学等级预测.
- 评估生存概率模型对LN状态分类的有用性.
主要方法:
- 使用了来自三个大队伍 (TCGA,METABRIC,SCAN) 的mRNA表达数据.
- 应用机器学习算法 (AdaBoost,XGBoost) 来分类LN状态和组织学等级.
- 使用接收器操作特征曲线 (AUC) 下的面积来评估模型性能.
主要成果:
- 对于LN预测的最大AUC为0.613 (XGBoost) 和0.604 (AdaBoost),表明准确性有限.
- 组织学等级的分子预测实现了显著更高的AUC (高达0.901).
- 生存概率模型显示AUC低于0.6用于LN预测.
结论:
- 单独的mRNA表达特征不足以可靠地预测乳腺癌中的淋巴结状况.
- 目前没有基于mRNA的模型是手术LN评估的可行替代方案.
- 未来的研究应该专注于整合性方法,将分子,空间和临床数据结合起来,以改善预测.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
03:18Non-LTR Retrotransposons
11.9K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K